neuropathic pain
Administration of spironolactone (10 and 20 mg/kg) significantly attenuated chronic constriction injury-induced pain related behaviour and foot deformity along with attenuation of TNF-? levels, without modulating vincristine-induced neuropathic pain.
Administration of spironolactone (10 and 20 mg/kg) significantly attenuated chronic constriction injury-induced pain related behaviour and foot deformity along with attenuation of <span class="gene" id="20846523-8-180-185">TNF-&alpha;</span> levels, without modulating vincristine-induced <span class="disease" id="20846523-8-233-249">neuropathic pain</span>.